
G-Neostigmine0.5 mg/ml
Gonoshasthaya Pharmaceuticals Limited
Neostigmine Methyl Sulphate is a reversible acetylcholinesterase inhibitor with the following clinically established uses: Reversal of non-depolarizing neuromuscular blockade: FDA-approved for…
Neostigmine Methyl Sulphate is a reversible acetylcholinesterase inhibitor with the following clinically established uses:
Neostigmine Methyl Sulphate is administered only by trained healthcare personnel with appropriate monitoring equipment available.
| Indication | Adult Dose | Notes |
|---|---|---|
| Reversal of non-depolarizing neuromuscular blockade | 0.03–0.07 mg/kg IV bolus (maximum total dose 0.07 mg/kg or 5 mg, whichever is less); may repeat based on response and neuromuscular monitoring | Must be given with an anticholinergic agent (atropine ~15 mcg/kg IV or glycopyrrolate ~10 mcg/kg IV) shortly before or concurrently; use only when first twitch response has recovered to at least 10% of baseline on a peripheral nerve stimulator |
| Myasthenia gravis (parenteral) | 1–2.5 mg IM or SC at appropriately spaced intervals; total daily dose individualized (commonly 5–20 mg/day) according to response | Dose is titrated to the smallest amount that controls symptoms without inducing cholinergic side effects; oral therapy resumed as soon as feasible |
| Postoperative/postpartum non-obstructive urinary retention | 0.25–0.5 mg IM or SC, repeated every 3 to 6 hours as needed | Only after mechanical obstruction has been excluded |
| Postoperative abdominal distension (paralytic ileus) | 0.25–0.5 mg IM or SC, repeated every 3 to 6 hours as needed | Only after mechanical obstruction/peritonitis has been excluded |
Neostigmine Methyl Sulphate must be administered by trained healthcare personnel with resuscitation equipment, oxygen, and atropine immediately available. It is given by intravenous, intramuscular, or subcutaneous injection as appropriate to the indication; it is not given orally in this formulation.
Side effects of Neostigmine Methyl Sulphate arise mainly from excessive cholinergic (muscarinic and nicotinic) stimulation:
Excessive dosing can precipitate a cholinergic crisis (see Overdose).
Neostigmine Methyl Sulphate is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.